ajcc 8th edition update*agps.org.au/resources/agm_stuff/2017_agm/ajcc 8th...rcpa colorectal cancer...
TRANSCRIPT
![Page 1: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/1.jpg)
AJCC 8th edition update*: Colorectal cancer
Dr Caroline Cooper
Pathology Queensland- Princess Alexandra Hospital, Brisbane
* and other prognostic controversies
![Page 2: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/2.jpg)
Chapter 20
• Colorectal adenocarcinoma
• High grade neuroendocrine carcinoma
• SCC colon and rectum
![Page 3: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/3.jpg)
8th edition updates and corrections
• https://cancerstaging.org/references-tools/deskreferences/Pages/8EUpdates.aspx
![Page 4: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/4.jpg)
Summary of changes
• pT4a – definition clarified
• Definition of tumour deposit
• Definition of distant metastasis
• Additional factors for clinical care
– LVI – reintroduced L and V
– MSI – clarified importance as predictive and prognostic factor
– KRAS, NRAS and BRAF mutations – identified importance as predictive and prognostic factors
![Page 5: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/5.jpg)
pT4
• Tumours involving serosal surface (visceral peritoneum)(pT4a)
• Tumours directly invading adjacent organs or structures (pT4b)
• Not applicable to portions of the colorectum that are not peritonealised – posterior ascending colon – posterior descending colon – lower portion of rectum
![Page 6: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/6.jpg)
pT4a – definition clarified
• Involvement of serosal surface by direct tumour extension
![Page 7: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/7.jpg)
![Page 8: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/8.jpg)
pT4a
• Tumours with perforation with tumour cells continuous with serosal surface through inflammation
![Page 9: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/9.jpg)
pT4a - controversies
• Tumours <1mm from serosal surface with a serosal reaction
– unclear ? Higher risk of peritoneal relapse
– Levels, further blocks if serosa not involved then pT3
• Use of elastin stain?
![Page 10: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/10.jpg)
0.6mm
![Page 11: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/11.jpg)
![Page 12: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/12.jpg)
![Page 13: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/13.jpg)
![Page 14: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/14.jpg)
Orcein=Incomplete elastic lamina
![Page 15: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/15.jpg)
pT4a – controversies
• Acellular mucin at or close to serosal surface
– Not considered pT4a
![Page 16: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/16.jpg)
pT4a – clinical significance
• Prognosis
• Peritoneal recurrence
• Choice of therapy
– NCCN guidelines – high risk features in stage II
• Likely chemotherapy
• Possible HIPEC (hyperthermic intraperitoneal chemotherapy)
![Page 17: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/17.jpg)
pN: Isolated tumour cells/ micrometastasis – definition clarified
• Are they significant?- depends on definition – conflicting data on outcome of ITC
• ITC: individual tumour cells in subcapsular or marginal sinus <0.2mm = pN0
• Micrometastasis: 0.2-2mm = pN1
• Do not need to use N0 (i+) or N1 (mic)
![Page 18: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/18.jpg)
Deposit = 0.1mm = pN0
![Page 19: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/19.jpg)
Tumour deposits – criteria redefined
• discrete tumour nodules within lymph drainage area of primary carcinoma, without identifiable lymph node, vascular or neural structure
• Use pT1c if negative regional lymph nodes
• Shape, contour and size not considered
• No minimum size or distance from invasive front
• Location: subserosa, mesentery, nonperitonealised pericolic, perirectal/ mesorectal tissue
![Page 20: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/20.jpg)
![Page 21: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/21.jpg)
Tumour deposits changes
• If vessel wall or remnant identified = LVI – small vessel
– venous invasion (tumour within endothelial lined space containing red cells or surrounded by smooth muscle) (elastic stain may be helpful) • Intramural = submucosa or m. propria
• Extramural = beyond m. propria
• If nerve identifiable = PNI
![Page 22: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/22.jpg)
Extramural venous invasion
![Page 23: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/23.jpg)
![Page 24: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/24.jpg)
![Page 25: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/25.jpg)
TD- due to perineural spread
![Page 26: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/26.jpg)
![Page 27: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/27.jpg)
Tumour deposits - controversies
• TD can show small focus of LVI or PNI ?What to do
• If neoadjuvant therapy – “important for the pathologist to assess whether tumour nodules represent tumour deposits…or discontinuous eradication of the original tumour….”(pg 261)
![Page 28: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/28.jpg)
pM
• Addition of pM1c - peritoneal carcinomatosis
• 1-4% of cases
• Prognosis worse than visceral metastasis
![Page 29: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/29.jpg)
![Page 30: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/30.jpg)
Molecular
• MSI
• KRAS, NRAS
• BRAF
![Page 31: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/31.jpg)
![Page 32: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/32.jpg)
*and other prognostic controversies
• Tumour grading
• Grading mucinous adenocarcinomas
• Tumour budding
• Acellular mucin in lymph nodes (and elsewhere)- non-neoadjuvant setting
• Circumferential resection margin
• Post neoadjuvant Rx – ypT
![Page 33: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/33.jpg)
![Page 34: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/34.jpg)
Tumour grade – how much is enough?? ¯\_(ツ)_/¯
• Important prognostic parameter
• No consensus on grading system
– 2, 3 or 4 tiered
– Significant interobserver variability
![Page 35: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/35.jpg)
WHO histological classification
• Well differentiated adenocarcinoma shows glandular structures in >95% of the tumour.
• Moderately differentiated adenocarcinoma show 50–95%glandular structures.
• Poorly differentiated adenocarcinoma show 0-49% glandular structures.
• Low grade= well + moderate
• High grade = poor/ undifferentiated
![Page 36: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/36.jpg)
TNM
• Grade 1= well
• Grade 2= moderate
• Grade 3= poor
• Grade 4= undifferentiated
![Page 37: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/37.jpg)
How to grade?
• Difference in grade between superficial and invasive front
– ? % gland formation
– ? Worst pattern (regardless of amount)
![Page 38: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/38.jpg)
![Page 39: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/39.jpg)
Should it involve MSI?
YES! (for high grade)
![Page 40: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/40.jpg)
Grading mucinous adenocarcinomas
![Page 41: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/41.jpg)
Should it involve MSI?
YES!
MSH1 PMS2
MSH2 MSH6
![Page 42: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/42.jpg)
Tumour budding in CRC
• Independent prognostic factor
– High risk in stage II
• Not included in AJCC 8th ed, NCCN guidelines
• Recommended in some structured reports inc RCPA, UK
![Page 43: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/43.jpg)
![Page 44: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/44.jpg)
Tumour budding: recommendations
• Assess on H&E
• Single cell or cell cluster <= 4 tumour cells
• Assess in one hotspot at the invasive tumour front
• Budding count + 3 tier system (bud count/0.785mm2 field)
– Bd1 (low) 0-4 buds
– Bd2 (intermediate) 5-9 buds
– Bd3 (high) >=10 buds
![Page 45: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/45.jpg)
![Page 46: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/46.jpg)
![Page 47: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/47.jpg)
Acellular mucin in lymph nodes – what does it mean? ¯\_(ツ)_/¯
• Post neoadjuvant – no influence on local recurrence
• Controversial in the non-neoadjuvant setting
– LN with mucin categorised as pN1 when malignant cells identified
– How does mucin reach LN without neoplastic epithelium?
– Does it reflect overwhelming host response?
– Is it “mucin spillage” into lymphatics?
![Page 48: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/48.jpg)
• Multiple levels
• Shepherd N Histopathol 2016; 69: 522-8 regard this as metastatic disease with designation pN1 (acellular mucin)
• Rare, may not be able to gather enough data to provide information on staging
![Page 49: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/49.jpg)
Acellular mucin elsewhere……?
Image courtesy of I Brown
![Page 50: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/50.jpg)
Circumferential resection margins (CRM)
• Distance from deepest point of tumour invasion and retroperitoneal or mesenteric resection margin
• One of most important determinants of local control in colon and rectal cancer
• 0-1mm= high risk of recurrence and decreased survival
• What about lymph nodes near the CRM?
![Page 51: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/51.jpg)
RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016
• “Any lymph nodes lying close to the non-peritonealised resection margin need to be sampled in continuity with that margin. If there is tumour in any of the lymph nodes then it is the measurement from the involved lymph node to the nonperitonealised resection margin, if it is closer, rather than from the primary tumour, that is important. This is also true for any isolated tumour deposit in the perirectal or pericolic fat.”
![Page 52: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/52.jpg)
• Example of TD near CRM
![Page 53: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/53.jpg)
¯\_(ツ)_/¯
• What if a positive lymph node is transected at the CRM but the location of the tumour deposit in the node is >1mm from the margin?
Image courtesy of M Strauss via I Brown
![Page 54: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/54.jpg)
Post neoadjuvant treatment ypT
• How to define “viable tumour cells”
![Page 55: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/55.jpg)
¯\_(ツ)_/¯
• Large mucin pool containing few viable tumour cells at one edge? Is the entire mucin pool regarded as viable tumour?
• How to stage when abundant mucin and few viable tumour cells- and mucin crosses boundaries for T staging?
![Page 56: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/56.jpg)
m.propria
Acellular mucin
Viable tumour
![Page 57: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/57.jpg)
Post CT/RT with one gland in a LN 1mm from the CRM-? Is the gland viable ?what
does this mean
![Page 58: AJCC 8th edition update*agps.org.au/resources/AGM_Stuff/2017_AGM/AJCC 8th...RCPA Colorectal cancer Structured reporting protocol 3rd Ed 2016 • ^Any lymph nodes lying close to the](https://reader035.vdocuments.site/reader035/viewer/2022071500/611ee70d22da420366144093/html5/thumbnails/58.jpg)
Acknowledgments
• Ian Brown and colleagues at Envoi